Entesar Farghly Amin (Entesar F Amin)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Angiotensin Converting Enzyme

Ischemia Reperfusion Injury

Anti Inflammatory

Top Venues

The Journal of pharmacy and pharmacology

Fundamental & clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Marwa Monier Mahmoud Refaie, Entesar Farghly Amin, Marwa Nadi Hassan, Rehab Ahmed Rifaai, Asmaa M A Bayoumi, Maha Yehia Kamel
Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway. The Journal of pharmacy and pharmacology 76 (7) (2024)
Marwa Monier Mahmoud Refaie, Entesar Farghly Amin, Marwa Nadi Hassan, Rehab Ahmed Rifaai, Asmaa M A Bayoumi, Maha Yehia Kamel
Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway. The Journal of pharmacy and pharmacology (2024)
Entesar Farghly Amin, Rehab Ahmed Rifaai, Rania G Abdel-Latif
Empagliflozin attenuates transient cerebral ischemia/reperfusion injury in hyperglycemic rats via repressing oxidative-inflammatory-apoptotic pathway. Fundamental & clinical pharmacology 34 (5) (2020)